Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Thursday 10 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 96 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
SYMPOSIUM<br />
hypoFrACTonATion And pArTiAl brEAsT rAdioThErApy<br />
lEaRning ObJECTivES:<br />
1. Adjustments to the number and size of fractions are not enough: inter-fraction<br />
interval, treatment volume and overall time are also clinically relevant<br />
2. There is evidence for a strong volume effect for late adverse effects after PBRT<br />
3. High single doses are well tolerated by the breast, and appear to be effective in<br />
reducing local relapse risk<br />
4. Bio-effect models can be constructed to help design accelerated PBRT schedules<br />
14:30 - 15:45 • Room 113-114<br />
ChaiR: J.R. Yarnold (United Kingdom)<br />
CO-ChaiR: R. Cabrera (Spain)<br />
14:30 > Hypofractionation and PBRT: what do we need to think about?<br />
SPEaKER: N. Somaiah (United Kingdom) SP-0095<br />
14:48 > Evidence of volume effects for normal tissue and tumour<br />
responses<br />
SPEaKER: E. Van Limbergen (Belgium) SP-0096<br />
15:06 > IORT update: what are the limits of total dose and volume?<br />
SPEaKER: R. Orecchia (Italy) SP-0097<br />
15:24 > Bio-effect models of hypofractionation in accelerated PBRT<br />
SPEaKER: S. Bentzen (USA) SP-0098<br />
SYMPOSIUM<br />
brAChyThErApy boosT or sib:<br />
TrEATMEnT oF ChoiCE For prosTATE CAnCEr?<br />
lEaRning ObJECTivES:<br />
1. To appreciate the contribution and utility of multi-modality parametric imaging for<br />
target volume definition and image guided strategies<br />
2. To understand the rationale, case selection and evidence for HDR brachytherapy<br />
for dose escalation<br />
Thursday 10 May 2012<br />
abS. numbER<br />
14:30 - 15:45 • Room 115<br />
ChaiR: V. Khoo (United Kingdom)<br />
CO-ChaiR: B. Pinar (Spain)<br />
14:30 > Promises and pitfalls of functional imaging for focal dose<br />
escalation in prostate cancer<br />
SPEaKER: G. Crehange (France) SP-0099<br />
14:55 > Comparison between brachytherapy and EBT with X-rays<br />
and protons. Dose distributions and peripheral doses<br />
SPEaKER: D.A. Mazal (France) SP-0100<br />
15:20 > Emerging data for high risk patients<br />
SPEaKER: P. Hoskin (United Kingdom) SP-0101<br />
LOOK INSIDE<br />
CUTTinG EdGE TEChnoloGy:<br />
CAn wE dEliVEr ThE dosE disTribUTion wE plAn?<br />
lEaRning ObJECTivES:<br />
1. To consider the current limitations on defining volumes and dose distributions,<br />
both technology-related and inherent<br />
2. To consider the limitations and uncertainties on delivering the required dose distributions<br />
with current technology<br />
3. To discuss the potential of technology developments to impact on and mitigate<br />
limitations and uncertainties<br />
4. To compare and contrast relevant factors and issues between radiotherapy treatment<br />
modalities (external beam MV X-ray, ion beam therapy, brachytherapy)<br />
14:30 - 15:45 • Room 117<br />
ChaiR: D. Ge<strong>org</strong> (Austria)<br />
CO-ChaiR: V. Hernandez (Spain)<br />
14:30 > Limitations in delivery of the required dose distributions<br />
for MV X-ray EBRT with current and developing technology<br />
SPEaKER: D.I. Thwaites (Australia) SP-0102<br />
14:55 > Ion beam therapy<br />
SPEaKER: C. Bert (Germany) SP-0103<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 97<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language